Why Spain?

A growing healthcare market, supported by public investment and European funding

Spain represents a strategic gateway for European healthcare companies seeking to expand through public procurement. It is one of the countries with the highest levels of public healthcare investment, allocating over €134 billion in 2025 alone. This sustained commitment reflects not only the scale of the system, but also its openness to innovation, international collaboration, and supplier diversification.

In addition to national investment, Spain is a key beneficiary of Next Generation EU funds, with more than €163 billion assigned between 2021 and 2026, including €48 billion earmarked for strategic projects in health, digitalisation, and sustainability. These funds are accelerating structural reforms, modernising procurement platforms, and creating new opportunities for companies with the capacity to deliver value in a regulated, competitive environment.

For suppliers with the right positioning, Spain offers a dynamic and expanding market, backed by long‑term public funding and a clear political commitment to strengthening its healthcare infrastructure. Entering this market through public tenders is not only feasible—it is a strategic move for companies aiming to grow sustainably in Europe’s institutional landscape.